In This Section
- Evidence-Based Resources
- Law and Health Policy
- Healthy People eLearning
- Program Planning
Predictions For 2020 2030
The Strategy (2016 – 2020) has two goals: five years of evidence-based action to maximize functional ability that reaches every person; and; by 2020, establish evidence and partnerships necessary to support a Decade of Healthy Ageing from 2020 to 2030. Checkbook pro 2 5 11 – manage personal checking accounts. Specifically the Strategy focuses on five strategic objectives. Checkpoint 1 1 – verify without copying documents.
- 29, 2020 - Data reported in the just published American Heart Association's Heart & Stroke Statistics - 2020 Update, show heart disease and stroke deaths continue to decline, but.
- Rapid urbanisation Megatrends 2020-2030 Life is better in cities Global migration to cities Growth of Asian and African megacities Healthcare and security become key Smart cities, new infrastructure Cities become more powerful than nations CHANGESIMPACTS Sources: BlackRock, Bloomberg, Deloitte, IFTF, McKinsey, PwC, WEF, World Bank 9.
- May 19, 2020 There’s a Lot Less Pollution But Climate Change Is Still Getting Worse These studies are not going to make you feel better about the pandemic’s effects on warming.
- Houston Texans, 75% 2. New England Patriots, 74% 3. Green Bay Packers, 73% 4. Cleveland Browns, 73% 5. Indianapolis Colts, 72% 6. Tennessee Titans, 72%.
![Better Blocker 2020 2030 Better Blocker 2020 2030](https://www.herald.co.zw/wp-content/uploads/sites/2/2020/10/PFUMVUDZA-MANICALAND.jpg)
![2030 2030](https://ioby.org/sites/default/files/20180519_073557.jpg)
Better Blocker 2020 2030 Schedule
Beta-Blockers for Preventing Stroke Recurrence
Beta-blockers are drugs that reduce heart rate and blood pressure, and have other effects that might also reduce the risks of stroke and heart attack. This systematic review sought to evaluate the efficacy of beta-blockers for preventing stroke recurrence and for reducing death and major vascular events in people with a previous stroke or transient ischemic attack (TIA), and to determine their safety. This review identified 2 high quality trials and found no clear evidence that beta-blockers reduced the risk of stroke, heart attack, or death from vascular disease. Participants who received beta-blockers instead of placebo showed significantly more adverse effects. More studies with larger samples are needed.
Evidence-Based Resource Details
Learn more about EBR criteriaDe Lima LG, Saconato H, Atallah ÁN, da Silva EMK. Beta-blockers for preventing stroke recurrence. Cochrane Database Syst Rev [Internet]. 2014 [cited 2017 Dec 29];(10). Art. No.: CD007890. doi: 10.1002/14651858.CD007890.pub3. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007890.pub3/full
2020 2030 Calendar
The Healthy People 2020 evidence-based resources identified have been selected by subject matter experts at the U.S. Department of Health and Human Services. Each of the selected evidence-based resources has been rated and classified according to a set of specific criteria based, in part, on publication status, publication type, and number of studies. This classification scheme does no necessarily consider all dimensions of quality, such as statistical significance, effect size (e.g., magnitude of effect), meaningfulness of effect, additional effect over control, and study design (e.g., sample size, power, internal validity, external validity, generalizability, potential biases, potential confounders).